Bimatoprost drug delivery with fractional laser and microneedling for the management of COVID-19 prone positioning-induced facial atrophy and hypopigmentation. uri icon

Overview

publication date

  • July 15, 2021

Identity

PubMed Central ID

  • PMC8280367

Scopus Document Identifier

  • 85062692518

Digital Object Identifier (DOI)

  • 10.1097/DSS.0000000000001678

PubMed ID

  • 34307814

Additional Document Info

volume

  • 15